ILUVIEN 190 micrograms intravitreal implant in applicator (fluocinolone acetonide)

Similar documents
Package leaflet: information for the user. OZURDEX 700 micrograms intravitreal implant in applicator dexamethasone

PATIENT INFORMATION LEAFLET. PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM OZURDEX, dexamethasone 700 μg intravitreal implant

ILUVIEN 190 micrograms intravitreal implant in applicator (fluocinolone acetonide)

Package leaflet: Information for the patient. IKERVIS 1 mg/ml, eye drops, emulsion ciclosporin

Package leaflet: Information for the patient. Verkazia 1 mg/ml eye drops emulsion ciclosporin

Package Leaflet: Information for the user. LUMIGAN 0.3 mg/ml, eye drops, solution, in single-dose container Bimatoprost

Package leaflet: Information for the user. Bupivacaine 0.25% w/v, 0.5% w/v solution for injection Bupivacaine Hydrochloride

PATIENT INFORMATION LEAFLET. PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM LUMIGAN 0,01 %, bimatoprost 0,1 mg/ml eye drops

PATIENT INFORMATION LEAFLET

PRED FORTE 1% w/v Eye Drops, Suspension Prednisolone acetate

Pilocarpine 2% w/v Eye Drops, solution. Pilocarpine 4% w/v Eye Drops, solution. Pilocarpine Hydrochloride

Package leaflet: Information for the user. NEVANAC 1 mg/ml eye drops, suspension Nepafenac

Package leaflet: Information for the user. <product name> 3 mg/ml eye drops, solution. Ofloxacin

Package leaflet: Information for the user. PRED MILD STERILE OPHTHALMIC SUSPENSION 0.12% w/v Eye Drops, Suspension Prednisolone Acetate

Package Leaflet: Information for the user. NEVANAC 3 mg/ml eye drops, suspension nepafenac

Proposed PIL NL/H/0653/001/IB/024/G. MONOFREE DEXAMETHASON 1 mg/ml, eye drops, solution in single-dose container Dexamethasone phosphate

Ophthalmology. Ophthalmology Services

PACKAGE LEAFLET: INFORMATION FOR THE USER Pulmicort Turbohaler budesonide. 1. What Pulmicort Turbohaler is and what it is used for

Package leaflet: Information for the patient. Xemacort 20 mg/g + 1 mg/g cream (fusidic acid and betamethasone)

Patient Information Cataract Surgery

2. What you need to know before Marcain Polyamp Steripack is given to you

Dorzolamide 20 mg/ml Eye Drops, Solution

PACKAGE LEAFLET: INFORMATION FOR THE USER ToboDexin 3 mg/g+1 mg/g eye ointment Tobramycin + Dexamethasone

Package leaflet: Information for the patient. Dexametason Abcur 4 mg tablets. Dexamethasone

Package Leaflet - Information for the User. TOBRADEX 3 mg/ml/1 mg/ml Eye Drops, Suspension Tobramycin and Dexamethasone

GENERAL INFORMATION DIABETIC EYE DISEASE

Some general information on hepatitis A infection is given at the end of this leaflet.

Package leaflet: Information for the patient. Brimonidine Biogaran 2 mg/ml eye drops, solution. brimonidine tartrate

Here s what you need to know about your treatment with JETREA (ocriplasmin)

Package leaflet: Information for the user. Latanoprost Pfizer 50 micrograms/ml Eye drops, solution Latanoprost

PACKAGE LEAFLET: INFORMATION FOR THE USER ACULAR 0.5% w/v EYE DROPS, SOLUTION (Ketorolac trometamol)

PACKAGE LEAFLET: INFORMATION FOR THE USER. Lidokain Isdin 40 mg/g cream. Lidocaine

Package leaflet: Information for the user Pulmicort Respules 0.5 mg, Nebuliser Suspension budesonide

Patient Leaflet : Information for the user Locoid Cream 0.1% w/w Hydrocortisone butyrate

Diabetic Eye Disease

PACKAGE LEAFLET: INFORMATION FOR THE USER

FASTUM 2.5% gel PACKAGE LEAFLET: INFORMATION FOR THE USER. What is in this leaflet? 1. WHAT FASTUM GEL IS AND WHAT IT IS USED FOR

1. What Naropin is and what it is used for

2 What you need to know before you use Beconase. Package Leaflet: Information for the user

Proctosedyl Ointment Hydrocortisone/Cinchocaine hydrochloride/framycetin sulphate/aesculin

IMOVAX POLIO POLIOMYELITIS VACCINE (INACTIVATED) Suspension for injection in prefilled syringe

เอกสารกาก บยาภาษาอ งกฤษ. AVAXIM 160 U Suspension for injection in a prefilled syringe Hepatitis A vaccine (inactivated, adsorbed)

Diabetes & Your Eyes

Cataract Surgery. Patient Information. How your care will be organised. Introduction

Package leaflet: Information for the user Oftaquix 5 mg/ml eye drops, solution. Levofloxacin

Package leaflet: Information for the patient. NEGABAN 1g, powder for solution for injection or infusion Temocillin

PACKAGE LEAFLET: INFORMATION FOR THE USER Rhinocort Aqua, 64 micrograms, Nasal Spray Budesonide

1 What Flixonase is and what it is used for

Zofran syrup contains a medicine called ondansetron. This belongs to a group of medicines called anti-emetics.

Package Leaflet: Information for the patient. Eylea 40 mg/ml solution for injection in a vial Aflibercept

Easyhaler Beclometasone 200 micrograms/dose inhalation powder

Package leaflet: Information for the user

PACKAGE LEAFLET: INFORMATION FOR THE USER. Rectogesic 4 mg/g Rectal Ointment Glyceryl trinitrate

Package leaflet: Information for the user. Xalatan 50 micrograms/ml Eye drops, solution Latanoprost

Patient Information Leaflet

Package leaflet: Information for the patient

PACKAGE LEAFLET: INFORMATION FOR THE PATIENT. Beclometasone dipropionate

Package leaflet: Information for the user. Cyclizine Lactate 50 mg/ml Injection

Read all of this leaflet carefully before you start taking this medicine.

Ophthamology Directorate. Eye Injection for Macular Disorders Information for Patients

Facts About Diabetic Eye Disease

LYSOBACT COMPLETE SPRAY ( ) mg / ml Oromucosal spray, solution

Read all of this leaflet carefully before you start using this medicine because it contains important information for you.

Package leaflet: Information for the user

PATIENT INFORMATION LEAFLET

Package leaflet: Information for the user. Cefixime ABR 100 mg/5 ml powder for oral suspension Cefixime

1 What Zofran Suppositories are and what they are used for

Intravitreal Injection

Age-Related Macular Degeneration (AMD)

Package leaflet: Information for the user. Zoladex LA 10.8 mg Implant goserelin

Information for patients

Package leaflet: Information for the user. Zidoval 7.5 mg/g Vaginal Gel Metronidazole

Package leaflet: Information for the user. Qvar 50 & 100 aerosol Beclometasone Dipropionate

Package leaflet: Information for the user. Carmellose sodium

Ventolin Accuhaler 200 micrograms salbutamol sulfate

What you can expect with OZURDEX

2 What you need to know before you use Zofran Suppositories

Read all of this leaflet carefully before you start taking this medicine.

Package leaflet: Information for the user. Exembol 1 mg/ml solution for infusion. argatroban monohydrate

Havrix Monodose Vaccine Hepatitis A Vaccine (Inactivated, adsorbed) ELISA Units/1 ml Suspension for Injection in a pre-filled syringe

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. [new-ka la]

Zofran syrup contains a medicine called ondansetron. This belongs to a group of medicines called anti-emetics.

Package leaflet: Information for the patient. Orgalutran 0.25 mg/0.5 ml solution for injection Ganirelix

Diabetic retinopathy damage to the blood vessels in the retina. Cataract clouding of the eye s lens. Cataracts develop at an earlier age in people

PACKAGE LEAFLET: INFORMATION FOR THE USER AMITIZA 24 MICROGRAM SOFT CAPSULES. Lubiprostone

ALPHAGAN EYE DROPS BRIMONIDINE TARTRATE

TREANA 5mg and 10mg Film-coated Tablets

TAFEN NASAL 50mcg nasal spray, suspension

FLIXONASE NASULE DROPS Fluticasone propionate

Flixotide Accuhaler 50 micrograms, 100 micrograms, 250 micrograms, 500 micrograms

1. What Xylocaine with adrenaline is and what it is used for

Package Leaflet: Information for the User Zotron 4mg/2ml (ή 8mg/4ml) Solution for Injection or Infusion ondansetron

PACKAGE LEAFLET: INFORMATION FOR THE USER

Package leaflet: Information for the patient. Latanoprost 50 micrograms/ml eye drops, solution latanoprost

D-Gam 250 micrograms/ml. Solution for injection. human anti-d immunoglobulin

Package leaflet: Information for the user. Burinex 5 mg Tablets bumetanide

Package leaflet: Information for the user

Irbenida 150 mg film-coated tablets; 300 mg film-coated tablets

Transcription:

ILUVIEN 190 micrograms intravitreal implant in applicator (fluocinolone acetonide) Read all of this information carefully before you are given this medicine because it contains important information for you. Keep this leaflet. You may need to read it again. If you have any further questions, ask your doctor. If you get any side effects, talk to your doctor. This includes any possible side effects not listed in this leaflet. What is in this leaflet 1. What ILUVIEN is and what it is used for 2. What you need to know before you are given ILUVIEN 3. How ILUVIEN is administered 4. Possible side effects 5. How to store ILUVIEN 6. Contents of the pack and other information

What ILUVIEN is and what it is used for ILUVIEN is a tiny tube that is inserted into the eye and releases very small amounts of the active ingredient, fluocinolone acetonide, for up to 3 years. Fluocinolone acetonide belongs to a group of medicines called corticosteroids. ILUVIEN is used to treat vision loss associated with diabetic macular oedema when other available treatments have failed to help. Diabetic macular oedema is a condition that affects some people with diabetes, and causes damage to the light-sensitive layer at the back of the eye responsible for central vision, the macula. The active ingredient (the drug fluocinolone acetonide) helps to reduce the inflammation and the swelling that builds up in the macula in this condition. ILUVIEN can therefore help to improve the damaged vision or stop it from getting worse. What you need to know before you are given ILUVIEN You must not receive ILUVIEN:

If you are allergic (hypersensitive) to fluocinolone acetonide or any of the other ingredients of ILUVIEN listed at the end of this leaflet (see Section 6). If you have an infection of any kind in or around your eye. If you have glaucoma (high pressure inside your eye).

Warnings and precautions Before your ILUVIEN injection tell your doctor if: You are taking any medicines to thin the blood You have had a herpes simplex infection in your eye in the past (an ulcer on the eye that has been there a long time). ILUVIEN is given as an injection into the eye. Occasionally the injection may cause an infection inside the eye, pain or redness in the eye, or a detachment or tear of the retina. It is important to identify and treat these as soon as possible. Please tell your doctor immediately if you develop increased eye pain or discomfort, worsening redness of your eye, flashing lights and sudden increase in floaters, partially blocked vision, decreased vision or increased sensitivity to light after your injection. In some patients the eye pressure may increase with the possible development of glaucoma. This is something you may not notice; therefore you must be monitored by your doctor with visits to the clinic.

In the majority of patients who have not yet had an operation for cataracts, a clouding of the eye's natural lens (a cataract) may occur after treatment with ILUVIEN. If this occurs your vision will decrease, and you are likely to need an operation to remove the cataract. Your doctor will help you to decide when is the most appropriate time to perform this operation, but you should be aware that until you are ready for your operation your vision may be as bad or worse than it was before you received your ILUVIEN injection. The injection of ILUVIEN into both eyes at the same time has not been studied and is not recommended. Your doctor should not inject ILUVIEN into both eyes at the same time. Children and adolescents (below 18 years of age) The use of ILUVIEN in children and adolescents has not been studied and is therefore not recommended. Other medicines and ILUVIEN Please tell your doctor if you are using or

have recently used any other medicines, including medicines bought without a prescription. Pregnancy and breast-feeding There is no experience of using ILUVIEN in pregnant women; therefore the potential risks are unknown. If you are pregnant or planning to become pregnant, please discuss this with your doctor before ILUVIEN treatment. ILUVIEN is not recommended during breastfeeding because it is not known whether ILUVIEN passes into human milk. Ask your doctor or pharmacist for advice before ILUVIEN treatment.

Driving and using machines After ILUVIEN treatment you may experience some temporary vision blurring. If this happens, do not drive or use machines until this resolves. How ILUVIEN is administered The ILUVIEN injection will be administered by your eye doctor. ILUVIEN is given as a single injection into your eye. Afterwards, your doctor will monitor your vision regularly. Before the injection, your doctor will use antibiotic eye drops and wash your eye carefully to prevent infection. Your doctor will also give you a local anaesthetic to prevent any pain that the injection might cause. Before and after the injection, your doctor may ask you to use antibiotic eye drops in order to prevent any possible eye infection. Please follow these instructions carefully. If the effect of the implant wears off and your

doctor recommends it, another implant may be injected into your eye. If you have any further questions on the use of this product, ask your doctor. Possible side effects Like all medicines, ILUVIEN can cause side effects, although not everybody gets them. With administration of ILUVIEN, there may be some side effects, mostly in the eye. Occasionally the injection may cause an infection inside the eye, pain or redness in the eye, or a detachment or tear of the retina. It is important to identify and treat these as soon as possible. Please tell your doctor immediately if you develop increased eye pain or discomfort, worsening redness of your eye, flashing lights and sudden increase in floaters, partial blocked vision, decreased vision or increased sensitivity to light after your injection. Other side effects may include increased eye pressure or clouding of the eye s natural lens. Increased pressure in the eye which damages the optic nerve (glaucoma) may be more likely if the pressure inside your eye is higher than average before treatment. Your

doctor will discuss the risks of this with you before treatment. The symptoms you might experience and what you should do if you experience these symptoms are described in Section 2 of this leaflet (Warnings and precautions). The following side effects have been observed in clinical studies done with ILUVIEN: Very common (affects more than 1 in 10 patients) Increased eye pressure, small particles or spots in vision (floaters), clouding of the eye's natural lens (cataract) or eye surgery to correct the cataract.

Common (affects between 1 and 10 in every 100 patients) Bleeding in the white part of your eye or inside the eye, increased pressure in the eye which damages the optic nerve (glaucoma), eye pain or irritation, reduced vision, or eye surgery or procedure to relieve increased eye pressure or to remove the gel material that fills the back of the eye. Uncommon (affects fewer than 1 in every 100 patients) Blockage of the blood vessels at the back of the eye, new blood vessel growth inside the eye, ulcer on the white of the eye, changes in the gel material that fills the back of the eye, clouding of the bag holding the lens of the eye, redness of the eye, itching or infection of the eye, thinning of the white outer layer of the eye, trauma to the eye from the injection of the medicine, unplanned movement of implant through white part of eye, and/or other complications from the injection. The most common non-visual side effect reported to be possibly caused by the drug or by the injection procedure is headache.

If you get any side effects, talk to your doctor. This includes any possible side effects not listed in this leaflet. How to store ILUVIEN Keep ILUVIEN out of the reach and sight of children. Do not use ILUVIEN after the expiry date which is stated on the carton and inner wrap after EXP. The expiry date refers to the last day of that month. Do not store above 30 C. Do not refrigerate or freeze. Keep the preloaded applicator with 25-gauge needle in the sealed tray. Once the sealed tray is opened, use immediately.